The universality of bioenergetic disease: the role of mitochondrial mutation and the putative inter-relationship between mitochondria and plasma membrane NADH oxidoreductase.
Lawen
A
A
Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.
Martinus
R D
RD
McMullen
G L
GL
Nagley
P
P
Vaillant
F
F
Wolvetang
E J
EJ
Linnane
A W
AW
D000255:Adenosine Triphosphate / Q000096:biosynthesis; D000375:Aging / Q000235:genetics / Q000378:metabolism; D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology; D002462:Cell Membrane / Q000201:enzymology*; D004272:DNA, Mitochondrial / Q000235:genetics*; D042967:Electron Transport Complex I; D004734:Energy Metabolism; D005292:Ferricyanides / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D008928:Mitochondria / Q000201:enzymology*; D017240:Mitochondrial Myopathies / Q000235:genetics*; D008954:Models, Biological; D009154:Mutation; D009243:NAD / Q000378:metabolism; D009247:NADH, NADPH Oxidoreductases / Q000235:genetics / Q000502:physiology*; D010084:Oxidation-Reduction
D000975:Antioxidants; D004272:DNA, Mitochondrial; D005292:Ferricyanides; D007166:Immunosuppressive Agents; D009243:NAD; C007931:hexacyanoferrate III; D000255:Adenosine Triphosphate; D009247:NADH, NADPH Oxidoreductases; D042967:Electron Transport Complex I